Viewing Study NCT04890093


Ignite Creation Date: 2025-12-25 @ 1:19 AM
Ignite Modification Date: 2025-12-25 @ 11:28 PM
Study NCT ID: NCT04890093
Status: RECRUITING
Last Update Posted: 2025-04-15
First Post: 2021-05-15
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module